Venture Capital

Anjarium Biosciences - Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.

Neurana Pharmaceuticals - Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.

Hyku - Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.

BioProcessors - Developing a technology, or platform, that is intended to speed up the drug-development process.

Quench Bio - Quench Bio is a developer of gasdermin biology drugs designed to treat severe inflammatory diseases.

Nanolive - Nanolive has developed a disruptive proprietary technology.

Borean Pharma - Borean Pharma ApS operates as a drug discovery and development company.

CiVi Biopharma - CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.

Curacyte AG - Curacyte AG is a bio pharmaceutical company that develops therapeutics for acute and critical care.

Zystor - ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal

© 2025 bioDAO.ai